| Hypothalamic-pituitary-adrenal axis and bipolar disorder C Daban, E Vieta, P Mackin, AH Young Psychiatric Clinics 28 (2), 469-480, 2005 | 353 | 2005 |
| Cardiac side effects of psychiatric drugs P Mackin Human Psychopharmacology: Clinical and Experimental 23 (S1), S3-S14, 2008 | 271 | 2008 |
| Wake-up call for British psychiatry N Craddock, D Antebi, MJ Attenburrow, A Bailey, A Carson, P Cowen, ... The British Journal of Psychiatry 193 (1), 6-9, 2008 | 250 | 2008 |
| Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia AH Barnett, P Mackin, I Chaudhry, A Farooqi, R Gadsby, A Heald, J Hill, ... Journal of Psychopharmacology 21 (4), 357-373, 2007 | 249 | 2007 |
| Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes L Manni, V Nikolova, D Vyagova, GN Chaldakov, L Aloe International journal of cardiology 102 (1), 169-171, 2005 | 241 | 2005 |
| Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community P Mackin, D Bishop, H Watkinson, P Gallagher, IN Ferrier The British Journal of Psychiatry 191 (1), 23-29, 2007 | 152 | 2007 |
| Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study P Mackin, HM Watkinson, AH Young Diabetologia 48, 215-221, 2005 | 150 | 2005 |
| HPA axis function in mood disorders S Watson, P Mackin Psychiatry 5 (5), 166-170, 2006 | 138 | 2006 |
| Antiglucocorticoid treatments for mood disorders P Gallagher, N Malik, J Newham, AH Young, IN Ferrier, P Mackin Cochrane Database of Systematic Reviews, 2008 | 130 | 2008 |
| A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients P Mackin, DR Bishop, HMO Watkinson BMC psychiatry 7, 1-6, 2007 | 123 | 2007 |
| Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM TA Chowdhury, MJ Dronsfield, S Kumar, SLC Gough, SP Gibson, ... Diabetologia 39, 1108-1114, 1996 | 97 | 1996 |
| Executive and visuospatial sketchpad resources in euthymic bipolar disorder: Implications for visuospatial working memory architecture JM Thompson, CJ Hamilton, JM Gray, JG Quinn, P Mackin, AH Young, ... Memory 14 (4), 437-451, 2006 | 81 | 2006 |
| Culture and assessment of manic symptoms P Mackin, SD Targum, A Kalali, D Rom, AH Young The British Journal of Psychiatry 189 (4), 379-380, 2006 | 67 | 2006 |
| Significance of microalbuminuria in long-duration type 1 diabetes CS Arun, J Stoddart, P Mackin, JM MacLeod, JP New, SM Marshall Diabetes Care 26 (7), 2144-2149, 2003 | 65 | 2003 |
| Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs LJ Hampson, P Mackin, L Agius Diabetologia 50, 1743-1751, 2007 | 54 | 2007 |
| Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia P Mackin, P Gallagher, S Watson, AH Young, I Nicol Ferrier Australian & New Zealand Journal of Psychiatry 41 (4), 321-326, 2007 | 54 | 2007 |
| Rapid cycling bipolar disorder: historical overview and focus on emerging treatments P Mackin, AH Young Bipolar disorders 6 (6), 523-529, 2004 | 54 | 2004 |
| Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin‐dependent diabetes mellitus TA Chowdhury, PH Dyer, S Kumar, SCL Gough, SP Gibson, BR Rowe, ... Diabetic medicine 14 (10), 837-840, 1997 | 51 | 1997 |
| Atypical antipsychotic drugs P Mackin, SHL Thomas Bmj 342, 2011 | 44 | 2011 |
| QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study P Mackin, AH Young Journal of Clinical Psychiatry 66 (11), 1386-1391, 2005 | 34 | 2005 |
